Literature DB >> 2574463

Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life.

D M Bowen1, A Najlerahim, A W Procter, P T Francis, E Murphy.   

Abstract

The extent and distribution of biochemical abnormalities thought to reflect disorders of subpopulations of neurons have been determined in the cerebral cortex from brains of patients with Alzheimer-type dementia and depressive illness who died of natural causes. In dementia, loss of gray matter from areas of the parietal and temporal lobes is most obvious. In depression, these areas are not affected, but the pars opercularis and temporal pole are smaller than in controls. Results expressed per unit mass of total protein indicate selective reductions in both disorders of serotonin 2 recognition sites in all areas examined and of somatostatin content in only the temporal pole of the six areas examined. In dementia alone a selective loss was found of somatostatin content of the superior parietal lobule and of serotonin 1A sites and choline acetyltransferase activity in all areas examined. Results for depression expressed per entire area indicate additionally reduced somatostatin content and serotonin 1A sites in the pars opercularis and serotonin 1A sites in the temporal pole. These multiple analyses performed on each sample provide further support for a prominent disorder of pyramidal neurons in dementia as well as more evidence for alterations in cortical neurons in depression, either as a result of the disease itself or its treatment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2574463      PMCID: PMC298525          DOI: 10.1073/pnas.86.23.9504

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Somatostatin content and receptors in the cerebral cortex of depressed and control subjects.

Authors:  B G Charlton; A Leake; C Wright; A F Fairbairn; I G McKeith; J M Candy; I N Ferrier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

2.  Brain 5-HT2 receptor binding sites in depressed suicide victims.

Authors:  S C Cheetham; M R Crompton; C L Katona; R W Horton
Journal:  Brain Res       Date:  1988-03-08       Impact factor: 3.252

Review 3.  Cholinergic function and intellectual decline in Alzheimer's disease.

Authors:  D Collerton
Journal:  Neuroscience       Date:  1986-09       Impact factor: 3.590

4.  Somatostatin immunoreactivity in postmortem brain from depressed suicides.

Authors:  B G Charlton; C Wright; A Leake; I N Ferrier; S C Cheetham; R W Horton; M R Crompton; C L Katona
Journal:  Arch Gen Psychiatry       Date:  1988-06

5.  Two distinct effects of 5-hydroxytryptamine on single cortical neurons.

Authors:  M F Davies; R A Deisz; D A Prince; S J Peroutka
Journal:  Brain Res       Date:  1987-10-13       Impact factor: 3.252

Review 6.  Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2)

Authors:  P W Gold; F K Goodwin; G P Chrousos
Journal:  N Engl J Med       Date:  1988-08-18       Impact factor: 91.245

7.  Cerebrospinal fluid somatostatin and psychiatric illness.

Authors:  D R Rubinow
Journal:  Biol Psychiatry       Date:  1986-04       Impact factor: 13.382

8.  Regional weight loss of the cerebral cortex and some subcortical nuclei in senile dementia of the Alzheimer type.

Authors:  A Najlerahim; D M Bowen
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

9.  5-HT receptor binding in post-mortem brain from patients with affective disorder.

Authors:  I G McKeith; E F Marshall; I N Ferrier; M M Armstrong; W N Kennedy; R H Perry; E K Perry; D Eccleston
Journal:  J Affect Disord       Date:  1987 Jul-Aug       Impact factor: 4.839

10.  Gamma-aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease.

Authors:  S L Lowe; P T Francis; A W Procter; A M Palmer; A N Davison; D M Bowen
Journal:  Brain       Date:  1988-08       Impact factor: 13.501

View more
  29 in total

Review 1.  Effects of medications on cerebral blood flow in late-life depression.

Authors:  Mitchell S Nobler; Kristian R Olvet; Harold A Sackeim
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

2.  Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms.

Authors:  A W Procter; P T Francis; G C Stratmann; D M Bowen
Journal:  Neurochem Res       Date:  1992-09       Impact factor: 3.996

Review 3.  Magnetic resonance in patients with affective illness.

Authors:  W M McDonald; K R Krishnan
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1992       Impact factor: 5.270

4.  Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635.

Authors:  Eydie L Moses-Kolko; Julie C Price; Michael E Thase; Carolyn Cidis Meltzer; David J Kupfer; Chester A Mathis; Wendy D Bogers; Susan R Berman; Patricia R Houck; Trisha N Schneider; Wayne C Drevets
Journal:  Synapse       Date:  2007-07       Impact factor: 2.562

Review 5.  5-HT(1A) receptor function in major depressive disorder.

Authors:  Jonathan Savitz; Irwin Lucki; Wayne C Drevets
Journal:  Prog Neurobiol       Date:  2009-02-07       Impact factor: 11.685

6.  Autobiographical deficits correlate with gray matter volume in depressed and high risk participants.

Authors:  Kymberly D Young; Patrick S F Bellgowan; Jerzy Bodurka; Wayne C Drevets
Journal:  Soc Cogn Affect Neurosci       Date:  2015-04-28       Impact factor: 3.436

Review 7.  Serotonergic therapies for cognitive symptoms in Alzheimer's disease: rationale and current status.

Authors:  Maria J Ramirez; Mitchell K P Lai; Rosa M Tordera; Paul T Francis
Journal:  Drugs       Date:  2014-05       Impact factor: 9.546

Review 8.  Imaging phenotypes of major depressive disorder: genetic correlates.

Authors:  J B Savitz; W C Drevets
Journal:  Neuroscience       Date:  2009-04-07       Impact factor: 3.590

Review 9.  Neurocircuitry of mood disorders.

Authors:  Joseph L Price; Wayne C Drevets
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

Review 10.  Serotonin-1A receptor imaging in recurrent depression: replication and literature review.

Authors:  Wayne C Drevets; Michael E Thase; Eydie L Moses-Kolko; Julie Price; Ellen Frank; David J Kupfer; Chester Mathis
Journal:  Nucl Med Biol       Date:  2007-10       Impact factor: 2.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.